Epoch Investment Partners, Inc. Astrazeneca PLC Transaction History
Epoch Investment Partners, Inc.
- $19.4 Billion
- Q4 2024
A detailed history of Epoch Investment Partners, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Epoch Investment Partners, Inc. holds 2,026,912 shares of AZN stock, worth $158 Million. This represents 0.68% of its overall portfolio holdings.
Number of Shares
2,026,912
Previous 1,962,030
3.31%
Holding current value
$158 Million
Previous $153 Million
13.13%
% of portfolio
0.68%
Previous 0.71%
Shares
30 transactions
Others Institutions Holding AZN
# of Institutions
1,365Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.71 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.2 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.92 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.89 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.87 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $242B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...